Health Apr 18 FDA clears extra COVID booster for some high-risk, older Americans The Food and Drug Administration is allowing an extra dose of the omicron-targeted vaccine for anyone 65 and older if it's been four months since their last shot.
Health Dec 05 Pfizer seeks FDA authorization of updated COVID-19 shot for kids under 5 The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older.
Nation Nov 22 U.S. renews push for COVID boosters as holiday season approaches Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now.
Health Oct 12 U.S. approves omicron-specific boosters for kids as young as 5 The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5.
Health Oct 03 Seniors urged to get extra-strength flu vaccines this season Doctors have a message for vaccine-weary Americans: Don't skip your flu shot this fall. And for the first time, seniors are urged to get a special extra-strength kind.
Health Aug 31 WATCH: FDA approves update for COVID booster shots to target Omicron The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days.
Health May 17 FDA authorizes COVID booster shot for healthy 5 to 11 year-old children U.S. regulators have authorized a COVID-19 vaccine booster for healthy children ages 5 to 11.
Health Mar 23 WATCH: White House COVID task force holds news briefing The White House COVID task force held a news briefing on March 23. This comes the same day that Moderna said it's COVID-19 vaccine works in babies, toddlers and preschoolers.
Health Mar 09 Man who received first transplanted pig heart dies A Maryland hospital says the first person to receive a heart transplant from a pig has died.
Health Feb 11 More data needed on Pfizer's COVID-19 vaccine for kids under 5, FDA says The Food and Drug Administration had urged Pfizer and its partner BioNTech to apply for authorization of extra-low doses of its vaccine for the youngest children before clinical studies were finished. On Friday, the FDA reversed course.